HomeCNSP • NASDAQ
add
CNS Pharmaceuticals Inc
Previous close
$0.14
Day range
$0.14 - $0.14
Year range
$0.10 - $137.50
Market cap
4.52M USD
Avg Volume
2.56M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.53M | -37.20% |
Net income | -2.53M | 37.07% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.53M | 37.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.49M | -65.14% |
Total assets | 2.47M | -61.73% |
Total liabilities | 6.76M | 69.19% |
Total equity | -4.29M | — |
Shares outstanding | 32.15M | — |
Price to book | -0.05 | — |
Return on assets | -306.06% | — |
Return on capital | 150.70% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.53M | 37.07% |
Cash from operations | -1.65M | 51.50% |
Cash from investing | — | — |
Cash from financing | 2.33M | -9.52% |
Net change in cash | 676.33K | 181.36% |
Free cash flow | -688.58K | 69.40% |
About
Founded
2017
Headquarters
Website
Employees
3
